Picture of Shanghai Henlius Biotech logo

2696 Shanghai Henlius Biotech Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Shanghai Henlius Biotech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-875-994-957-694570
Depreciation
Amortisation
Non-Cash Items197133336299161
Unusual Items
Other Non-Cash Items
Changes in Working Capital1521165111,099-41.8
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-443-61090.49821,048
Capital Expenditures-501-557-1,131-1,365-1,011
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-632-955-5506.567.01
Acquisition of Business
Sale of Fixed Assets
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-1,133-1,512-1,681-1,359-1,004
Financing Cash Flow Items-53-54.7-83.4-115-130
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2,948996648858144
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,342-1,187-959518194